What is cybernetic?

developed in 1990, Cyberknife® is a device that focuses on radiation therapy on a clearly defined therapeutic place more precisely than traditional radiotherapy. The two main components of the system are a small linear particle accelerator and a robotic arm. With the source of radiation mounted on the robot, radiation therapy can be aimed at a well -walled anatomical site from different directions and angles, with possible relocation. Cyberknife® X -ray leads to tumors and other masses. Radiotherapists currently use Cyberknife® to treat various benign and malignant tumors and other medical diseases.

The United States Food and Drug Administration (FDA) first approved Cyberknife® to treat tumors in any body location in August 2001. The comparison system with conventional therapy did not lead to an improvement in the patient's survival. However, because it is more accurate, it will seeHowever, the evolution allows doctors to provide a higher dose of radiation in a shorter period with less collateral damage to normal tissue than could be in conventional therapy.

Cyberknife® is unique among all radiosurgical devices in that it does not require a rigid frame for accurate targeting. Conventional systems rely on the connection of the frames with the skull of the patient with aluminum or titanium screws to ensure precise delivery of radiation. For comparison, the Cyberknife® system facilitates the rapid and accurate supply of treatment by comparing the X -ray X -ray instruction on the flight with previously acquired tomography scanning, allowing the patient to be accurate and specific to the patient on the robotic healing bed, Roboco, Roboco, Roboco, Robocouch®. This allows the possibility of issuing a dose of radiation for several days or weeks, a process called fractionation. Fractionation allows healthy tissues to repair whileTumor cells with defective repair mechanisms continue to die.

Sold by the United States, Accuray, Cyberknife® is functional at approximately 150 locations around the world, with 100 therapeutic facilities only in the United States. About 40,000 patients were treated worldwide. Actor Patrick Swayze received radiation procedures for his pancreatic cancer using Cyberknife® technology in 2008. Cyberknife® was set up outside Stanford University in Newport Diagnostic Center in Newport Beach, California near its development point. Stanford University administered radiotherapy to more than 2,500 patients with the system.